摘要
We read with great interest the recently(Annals of Surgery,March,2021)published article by Kwon and collaborators(1)about the effects of autotransfusion of salvaged blood with single leukoreduction for liver transplant recipients with advanced hepatocellular carcinoma(HCC).This retrospective study assessed the impact of autotransfusion of salvaged blood with post-transplant tumor recurrence.